With fresh $155M round, Gilead's former top scientist moves forward with cancer-fighting startup
August 24, 2020 at 09:00 AM EDT
Kronos Bio plans to take its lead cancer drug into a pivotal trial next year.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Home | News | Travel | Restaurants | Nightlife | Things To Do | Shopping | Calendar | Directory | Real Estate | Blog | More
|